241 related articles for article (PubMed ID: 34448532)
1. A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
Shih TL; Lin KH; Chen RJ; Chen TY; Kao WT; Liu JW; Wang HH; Peng HY; Sun YY; Lu WJ
J Cell Mol Med; 2021 Oct; 25(19):9434-9446. PubMed ID: 34448532
[TBL] [Abstract][Full Text] [Related]
2. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
[TBL] [Abstract][Full Text] [Related]
3. Quercitrin inhibits platelet activation in arterial thrombosis.
Oh TW; Do HJ; Jeon JH; Kim K
Phytomedicine; 2021 Jan; 80():153363. PubMed ID: 33070081
[TBL] [Abstract][Full Text] [Related]
4. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
[TBL] [Abstract][Full Text] [Related]
6. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
[TBL] [Abstract][Full Text] [Related]
7. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation.
Gilio K; Munnix IC; Mangin P; Cosemans JM; Feijge MA; van der Meijden PE; Olieslagers S; Chrzanowska-Wodnicka MB; Lillian R; Schoenwaelder S; Koyasu S; Sage SO; Jackson SP; Heemskerk JW
J Biol Chem; 2009 Dec; 284(49):33750-62. PubMed ID: 19815551
[TBL] [Abstract][Full Text] [Related]
8. Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation.
Yao Y; Chen Y; Adili R; McKeown T; Chen P; Zhu G; Li D; Ling W; Ni H; Yang Y
J Nutr; 2017 Oct; 147(10):1917-1925. PubMed ID: 28855423
[No Abstract] [Full Text] [Related]
9. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
[TBL] [Abstract][Full Text] [Related]
10. Doxepin inhibits GPVI-dependent platelet Ca
Geue S; Walker-Allgaier B; Eißler D; Tegtmeyer R; Schaub M; Lang F; Gawaz M; Borst O; Münzer P
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C765-C774. PubMed ID: 28404545
[TBL] [Abstract][Full Text] [Related]
11. RXR Ligands Negatively Regulate Thrombosis and Hemostasis.
Unsworth AJ; Flora GD; Sasikumar P; Bye AP; Sage T; Kriek N; Crescente M; Gibbins JM
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):812-822. PubMed ID: 28254816
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
13. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
14. Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
Moraes LA; Spyridon M; Kaiser WJ; Jones CI; Sage T; Atherton RE; Gibbins JM
J Thromb Haemost; 2010 Mar; 8(3):577-87. PubMed ID: 20040043
[TBL] [Abstract][Full Text] [Related]
15. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment.
Tullemans BME; Veninga A; Fernandez DI; Aarts MJB; Eble JA; van der Meijden PEJ; Heemskerk JWM; Kuijpers MJE
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681859
[TBL] [Abstract][Full Text] [Related]
17. Artesunate as a glycoprotein VI antagonist for preventing platelet activation and thrombus formation.
Lu WJ; Tsai CH; Chen RJ; Huang LT; Chen TY; Chen LC; Wang HH; Peng HY; Sun YY; Lin KH
Biomed Pharmacother; 2022 Sep; 153():113531. PubMed ID: 36076516
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan.
Jiang P; Loyau S; Tchitchinadze M; Ropers J; Jondeau G; Jandrot-Perrus M
PLoS One; 2015; 10(6):e0128744. PubMed ID: 26052700
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target.
Fuentes E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077280
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]